Chimerix Inc (NASDAQ:CMRX)

1.66
Delayed Data
As of May 16
 -2.58 / -60.85%
Today’s Change
1.60
Today|||52-Week Range
9.29
-74.18%
Year-to-Date
Chimerix (CMRX) Q1 2022 Earnings Call Transcript
May 16 / MotleyFool.com - Paid Partner Content
JetBlue Goes Hostile on Spirit, but This Biopharma's Getting Hit Hard
May 16 / MotleyFool.com - Paid Partner Content
Here's Why Chimerix Stock Is Imploding Today
May 16 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close4.24
Today’s open1.94
Day’s range1.60 - 1.99
Volume37,953,416
Average volume (3 months)1,468,419
Market cap$369.9M
Data as of 05/16/2022

Growth & Valuation

Earnings growth (last year)-191.43%
Earnings growth (this year)+92.32%
Earnings growth (next 5 years)--
Revenue growth (last year)-63.16%
P/E ratio--
Price/Sales275.95
Price/Book5.38

Competitors

 Today’s
change
Today’s
% change
VRDNViridian Therapeutic...-0.22-1.63%
----
ESPREsperion Therapeutic...+0.11+1.90%
--Cassiopea SpA0.000.00%
Data as of 05/16/2022

Financials

Next reporting dateAugust 10, 2022
EPS forecast (this quarter)$0.33
Annual revenue (last year)$2.0M
Annual profit (last year)-$173.2M
Net profit margin-8,753.71%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Durham, North Carolina

Forecasts

Chart unavailable